Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA062406-03
Application #
2103618
Study Section
Special Emphasis Panel (SRC (68))
Project Start
1994-03-18
Project End
1997-12-31
Budget Start
1996-01-01
Budget End
1996-12-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Phuphanich, Surasak; Carson, Kathryn A; Grossman, Stuart A et al. (2008) Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma. Neuro Oncol 10:617-23
Grossman, Stuart A; Carson, Kathryn A; Batchelor, Tracy T et al. (2006) The effect of enzyme-inducing antiseizure drugs on the pharmacokinetics and tolerability of procarbazine hydrochloride. Clin Cancer Res 12:5174-81
He, X; Batchelor, T T; Grossman, S et al. (2004) Determination of procarbazine in human plasma by liquid chromatography with electrospray ionization mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 799:281-91
Gilbert, Mark R; Supko, Jeffrey G; Batchelor, Tracy et al. (2003) Phase I clinical and pharmacokinetic study of irinotecan in adults with recurrent malignant glioma. Clin Cancer Res 9:2940-9
Grossman, S A; Hochberg, F; Fisher, J et al. (1998) Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants. NABTT CNS Consortium. The New Approaches to Brain Tumor Therapy. Cancer Chemother Pharmacol 42:118-26
Fetell, M R; Grossman, S A; Fisher, J D et al. (1997) Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New Approaches to Brain Tumor Therapy Central Nervous System Consortium. J Clin Oncol 15:3121-8